Adherence to combination antiretroviral therapy in complex emergency settings

BMJ (Online)

Volumn 338, Issue 7692, 2009, Pages 423-

  Jacob, Shevin T ^a   Abongomera, George ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b JOINT CLINICAL RESEARCH CENTRE   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

AFRICA; EDITORIAL; EMERGENCY WARD; HEALTH CARE ACCESS; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; HEALTH SERVICE; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL PERSONNEL; MEDICAL RESEARCH; MORTALITY; PATIENT ATTITUDE; PATIENT COMPLIANCE; PREVALENCE; PRIORITY JOURNAL; UGANDA;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; EMERGENCY TREATMENT; HIV INFECTIONS; HUMANS; PATIENT COMPLIANCE; UGANDA;

EID: 61849161548     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.a2662     Document Type: Editorial

References (12)

1. Lowicki-Zucca M, Spiegel PB, Kelly S, Dehne KL, Walker N, Ghys PD. Estimates of HIV burden in emergencies. Sex Transm Infect 2008;84(S1):42-8.
2. Kiboneka A, Nyatia RJ, Nabiryo C, Anema A, Cooper CL, Fernandes KA, et al. Combination antiretroviral therapy in conflict affected population: outcomes from large cohort in northern Uganda. BMJ 2009;338:b201.
3. Harries AD, Nyangulu DS, Hargreaves NJ, Kaluwa O, Salaniponi FM. Preventing antiretroviral anarchy in sub-Saharan Africa. Lancet 2001;358:410-4.
4. Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, Singh S, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America. JAMA 2006;296:679-90.
5. Olupot-Olupot P, Katawera A, Cooper C, Small W, Anema A, Mills E. Adherence to antiretroviral therapy among a conflict-affected population in northeastern Uganda: a qualitative study. AIDS 2008;22:1882-4.
6. Betsi NA, Koudou BG, Cissé G, Tschannen AB, Pignol AM, Ouattara Y, et al. Effect of an armed conflict on human resources and health systems in Côte d'Ivoire: prevention of and care for people with HIV/AIDS. AIDS Care 2006;18:356-65.
7. Spiegel PB, Bennedsen AR, Claass J, Bruns L, Patterson N, Yiweza D, et al. Prevalence of HIV infection in conflict-affected and displaced people in seven sub-Saharan countries: a systematic review. Lancet 2007;369:2187-95.
8. Office of the United Nations High Commissioner for Refugees. Clinical guidelines for antiretroviral therapy management for displaced populations: Southern Africa. Geneva: 2007. www.unhcr.org/protect/PROTECTION/4683b0522.pdf.
9. Culbert H, Tu D, O'Brien DP, Ellman T, Mills C, Ford N, et al. HIV treatment in a conflict setting: outcomes and experiences from Bukavu, Democratic Republic of the Congo. PLoS Med 2007,4:794-8.
10. International Federation of Red Cross and Red Crescent Societies. Refugees and the impact of war on HIV. In: World disasters report: focus on HIV and AIDS. 2008. www.ifrc.org/publicat/wdr2008/summaries.asp.
11. Oyugi JH, Byakika-Tusiime J, Ragland K, Laeyendecker O, Mugerwa R, Kityo C, et al. Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda. AIDS 2007;21:965-71.
12. Muyingo SK, Walker SA, Reid A, Munderi P, Gibb D, Ssali F, et al. Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trial in Uganda and Zimbabwe. J AIDS 2008,48:468-75.